Firibastat, (originally named QGC001) is the first drug candidate of a new class of centrally acting antihypertensive agents, brain APA inhibitors. Firibastat acts as an antihypertensive drug and not as a hypotensive agent.
For research use only. We do not sell to patients.
Name | Firibastat ( QGC-001 ) |
---|---|
Iupac Chemical Name | (S)-3-amino-4-(((S)-2-amino-4-sulfobutyl)disulfaneyl)butane-1-sulfonic acid |
Synonyms | RB-150 ; QGC-001 ; RB150 ; QGC001 ; RB 150 ; QGC 001 ; Firibastat |
Molecular Formula | C8H20N2O6S4 |
Molecular Weight | 368.51 |
Smile | O=S(CC[C@H](N)CSSC[C@@H](N)CCS(=O)(O)=O)(O)=O |
InChiKey | HJPXZXVKLGEMGP-YUMQZZPRSA-N |
InChi | InChI=1S/C8H20N2O6S4/c9-7(1-3-19(11,12)13)5-17-18-6-8(10)2-4-20(14,15)16/h7-8H,1-6,9-10H2,(H,11,12,13)(H,14,15,16)/t7-,8-/m0/s1 |
CAS Number | 648927-86-0 |
Related CAS | 648927-86-0 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO, water |
Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |